IL17A and experimental autoimmune encephalomyelitis: To investigate the therapeutic potential of 6F01 mAb in the animal model of autoimmunity, the experimental autoimmune encephalomyelitis (EAE) mice were treated with 6F01 mAb three times a week, and the treatment with anti-IL-17A mAb was used as a positive control.